Stryker Corporation

Equities

SYK

US8636671013

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 04:00:02 2024-04-26 pm EDT			5-day change	1st Jan Change
335.6 ^USD	-0.46%		+3.13%	+12.07%

Apr. 15	Truist Securities Adjusts Stryker Price Target to $364 From $345	MT
Apr. 15	BTIG Adjusts Stryker's Price Target to $366 From $353	MT

Stryker Corporation Provides Earnings Guidance for the Year 2021

October 28, 2021 at 04:05 pm EDT

Stryker Corporation provided earnings guidance for the year 2021. The company now expect 2021 organic net sales growth to be in the range of 7% to 8% from 2019, and expect EPS will be positively impacted by approximately $0.05 to $0.10 for the full year.

Latest news about Stryker Corporation

Truist Securities Adjusts Stryker Price Target to $364 From $345	Apr. 15	MT
BTIG Adjusts Stryker's Price Target to $366 From $353	Apr. 15	MT
RBC Raises Price Target on Stryker to $386 From $360, Keeps Outperform Rating	Apr. 15	MT
Penumbra, Inc. : The underdog in healthcare	Apr. 11
TD Cowen Adjusts Price Target on Stryker to $400 From $365, Maintains Buy Rating	Apr. 11	MT
Citigroup Raises Price Target on Stryker to $406 From $362, Maintains Buy Rating	Apr. 03	MT
Stryker Launches Gamma4 Hip Fracture Nailing System in Europe	Mar. 26	CI
Activist investor Politan plans second proxy battle at Masimo, WSJ reports	Mar. 24	RE
Stryker Completes Acquisition of French Joint Replacement Firm Serf	Mar. 21	MT
Stryker Corporation completed the acquisition of Serf from SAS Menix.	Mar. 20	CI
Stryker Insider Sold Shares Worth $2,756,730, According to a Recent SEC Filing	Mar. 11	MT
Transcript : Stryker Corporation Presents at Citi?s 2024 Unplugged Medtech and Life Sciences Access Day, Feb-29-2024 01:45 PM	Feb. 29
The latest transactions by star fund managers	Feb. 15
Stryker Insider Sold Shares Worth $3,290,952, According to a Recent SEC Filing	Feb. 12	MT
Stryker Insider Sold Shares Worth $100,349,381, According to a Recent SEC Filing	Feb. 07	MT
Stryker Keeps Quarterly Dividend at $0.80 a Share, Payable April 30 to Shareholders as of March 29	Feb. 07	MT
Fed officials fail to convince investors, who are focused on earnings	Feb. 07
Stryker Declares Quarterly Dividend, Payable on April 30, 2024	Feb. 07	CI
ANALYST RECOMMENDATIONS : Caterpillar, Eli Lilly, Intel, Meta, T-Mobile...	Feb. 07
DA Davidson Raises Price Target on Stryker to $355 From $305, Cites Strong Sales Results, Keeps Buy/Add Rating	Feb. 01	MT
UBS Adjusts Stryker Price Target to $339 From $331, Maintains Neutral Rating	Jan. 31	MT
Deutsche Bank Raises Stryker Price Target to $345 From $300, Maintains Hold Rating	Jan. 31	MT
Citigroup Raises Price Target on Stryker to $362 From $340, Keeps Buy Rating	Jan. 31	MT
Evercore ISI Raises Price Target on Stryker to $340 From $320, Keeps Outperform Rating	Jan. 31	MT
Piper Sandler Adjusts Price Target on Stryker to $375 From $360, Keeps Overweight Rating	Jan. 31	MT

Chart Stryker Corporation

Duration

Period

More charts

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-04-30 - Q1 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Stryker Corporation

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

335.6 USD

Average target price

365.7 USD

Spread / Average Target

+8.96%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
STRYKER CORPORATION	+12.07%	128B
SMITH & NEPHEW PLC	-9.04%	10.51B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+0.91%	8.71B
INSPIRE MEDICAL SYSTEMS, INC.	+16.72%	7B
GLAUKOS CORPORATION	+25.15%	5.02B
AXONICS, INC.	+7.17%	3.39B
ENOVIS CORPORATION	-1.36%	3.02B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-8.73%	2.07B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-10.15%	2.06B
DOUBLE MEDICAL TECHNOLOGY INC.	-22.81%	1.73B

Medical Devices & Implants